Every year at least 1.5 million people suffer adverse effects from medication. These problems occur because people misunderstand labels, are unaware of drug interactions, or otherwise use medication improperly. The Food and Drug Administration's Safe Use Initiative seeks to identify preventable medication risks and develop solutions to them. The IOM held a workshop to discuss the FDA's Safe Use Initiative and other efforts to improve drug labeling and safety.
Table of Contents
|2 FDA Safe Use Initiative||3-10|
|3 Over-the-Counter Products||11-18|
|4 Initiatives to Advance Patient-Centered Drug Safety||19-32|
|5 Identifying Activities Around Which to Build Partnerships for Patient-Centered Drug Safety||33-48|
|6 How Can the Lessons of Health Literacy Be Used to Build Patient-Centered Outcomes for Safe Use?||49-56|
|Appendix A: Acronyms||61-62|
|Appendix B: Workshop Agenda||63-66|
|Appendix C: Workshop Speaker Biosketches||67-74|
The National Academies Press and the Transportation Research Board have partnered with Copyright Clearance Center to offer a variety of options for reusing our content. You may request permission to:
For most Academic and Educational uses no royalties will be charged although you are required to obtain a license and comply with the license terms and conditions.
For information on how to request permission to translate our work and for any other rights related query please click here.
For questions about using the Copyright.com service, please contact:
Copyright Clearance Center
22 Rosewood Drive
Danvers, MA 01923
Tel (toll free): 855/239-3415 (select option 1)
Loading stats for The Safe Use Initiative and Health Literacy: Workshop Summary...